Form 4: MetLife Director Daniel Glaser Reports Stock Transactions

MetLife, Inc. Director Daniel S. Glaser reported transactions involving common stock, including dividend reinvestment and shares held in a GRAT.

Summary

• Director Daniel S. Glaser of MetLife, Inc. reported a transaction on June 9, 2026.
• This transaction involved the acquisition of 7 shares of common stock at a price of $85.57 per share.
• The acquisition is described as an 'imputed reinvestment of dividends on deferred shares' under the MetLife Deferred Compensation Plan for Non-Management Directors.
• Following this transaction, Mr. Glaser beneficially owns 2,108 shares of common stock directly.
• Additionally, Mr. Glaser beneficially owns 198 shares indirectly through a Grantor Retained Annuity Trust (GRAT).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider transactions and dividend reinvestment rather than significant strategic shifts or performance indicators.

Positives

• Director Glaser's continued beneficial ownership of MetLife stock, with direct ownership of 2,108 shares.
• The reinvestment of dividends indicates a continued accumulation of shares through a director compensation plan.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insiders and directors, providing transparency on their holdings and transactions. This filing indicates ongoing participation in director compensation plans and indirect ownership structures.

Key Dates

Keywords

MetLife, Form 4, SEC Filing, Director, Stock Transaction, Beneficial Ownership, Common Stock, Deferred Compensation, GRAT